At Stanford, a treatment that aims magnetic pulses at the brain is showing results for people with treatment-resistant depression. It’s called SAINT, and here’s how it works.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company’s lead antibiotic candidate is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback